Aperçu des produits pour anti-EPH Receptor A2 (EPHA2) Anticorps

Full name:: anti-EPH Receptor A2 Anticorps (EPHA2)

Chez www.anticorps-enligne.fr sont 364 EPH Receptor A2 (EPHA2) Anticorps de 31 de différents fournisseurs disponibles. De plus, nous expédions EPH Receptor A2 Protéines (20) et EPH Receptor A2 Kits (10) et beaucoup plus de produits pour cette protéine. Un total de 417 EPH Receptor A2 produits sont actuellement listés.

Synonymes:: ARCC2, AW545284, CTPA, CTPP1, CTRCT6, Eck, epha2, epha2-A, G42, id:ibd5152, MGC89505, Myk2, rtk6, Sek-2, Sek2, XE10

afficher tous les anticorps	Gène	GeneID	UniProt
	EPHA2	1969	P29317
	EPHA2	366492
	EPHA2	13836	Q03145
Afficher toutes les espèces Afficher tous les synonymes

Réactivités les plus populaires pour anti-EPH Receptor A2 (EPHA2) Anticorps

Sélectionnez vos espèces et l'application

anti-Human EPH Receptor A2 Anticorps:

anti-Rat (Rattus) EPH Receptor A2 Anticorps:

anti-Mouse (Murine) EPH Receptor A2 Anticorps:

Tous anti-EPH Receptor A2 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

Pathways pertinentes pour anti-EPH Receptor A2 Anticorps

Signalisation RTK

Plus produit pour EPH Receptor A2 Anticorps

anti-EPH Receptor A2 Anticorps mieux référencés

Human Polyclonal EPH Receptor A2 Primary Antibody pour CyTOF, FACS - ABIN4899913 : Gopal, Bohonowych, Lema-Tome, Liu, Garrett-Mayer, Wang, Isaacs: A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. dans PLoS ONE 2011 (PubMed)
Show all 4 Pubmed References
Human Monoclonal EPH Receptor A2 Primary Antibody pour CyTOF, FACS - ABIN4899912 : Liao-Chan, Daine-Matsuoka, Heald, Wong, Lin, Cai, Lai, DAlessio, Theunissen: Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophores. dans PLoS ONE 2015 (PubMed)
Show all 4 Pubmed References
Mouse (Murine) Monoclonal EPH Receptor A2 Primary Antibody pour CyTOF, FACS - ABIN4899679 : De Robertis, Loiacono, Fusilli, Poeta, Mazza, Sanchez, Marchionni, Signori, Lamorte, Vescovi, Garcia-Foncillas, Fazio: Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2016 (PubMed)
Show all 3 Pubmed References
Human Monoclonal EPH Receptor A2 Primary Antibody pour IHC, ELISA - ABIN1724651 : Landen, Kinch, Sood: EphA2 as a target for ovarian cancer therapy. dans Expert opinion on therapeutic targets 2005 (PubMed)
Show all 2 Pubmed References
Human Polyclonal EPH Receptor A2 Primary Antibody pour IF (p), IHC (p) - ABIN669201 : Wu, Fu, Zhou, Gong, Liu, Qiao, Li: HIF-1? and HIF-2?: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation. dans PLoS ONE 2014 (PubMed)
Human Monoclonal EPH Receptor A2 Primary Antibody pour IHC, ELISA - ABIN966072 : Abraham, Knapp, Cheng, Snyder, Mittal, Bangari, Kinch, Wu, Dhariwal, Mohammed: Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2006 (PubMed)
Show all 2 Pubmed References
Human Monoclonal EPH Receptor A2 Primary Antibody pour FACS - ABIN4896889 : Udyavar, Wooten, Hoeksema, Bansal, Califano, Estrada, Schnell, Irish, Massion, Quaranta: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. dans Cancer research 2017 (PubMed)
Human Monoclonal EPH Receptor A2 Primary Antibody pour FACS - ABIN4896891 : Haas, Sciuto, Brunetto, Valvo, Signore, Fiori, di Martino, Giannetti, Morgante, Boe, Patrizii, Warnken, Schnölzer, Ciolfi, Di Stefano, Biffoni, Ricci-Vitiani, Pallini, De Maria: Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma. dans Cell stem cell 2017 (PubMed)

Plus d’anticorps contre EPH Receptor A2 partenaires d’interaction

Human EPH Receptor A2 (EPHA2) interaction partners

EphA2-mediates glutaminolysis through YAP (Montrer YAP1 Anticorps)/TAZ (Montrer TAZ Anticorps) activation in HER2 (Montrer ERBB2 Anticorps)-positive breast cancer and may serve as potential therapeutic targets in patients.
Data indicate a promising role for EPH receptor A2 (EPHA2) as a target in antibody treatments for melanoma.
These observations demonstrate that EphA2 affects the sensitivity to oxaliplatin by inducing EMT (Montrer ITK Anticorps) in oxaliplatin-resistant gastric cancer cells.
High erythropoietin (Montrer EPO Anticorps)-producing hepatocellular carcinoma receptor A (EphA) 1 (Montrer EPHA1 Anticorps), 2, and 4 expression levels were significantly related to recurrence.
Data show that Ephrin B3 (Montrer EFNB3 Anticorps) was concomitantly expressed with EphA2 and Ephrin A1 (Montrer EFNA1 Anticorps) with higher Ephrin B3 (Montrer EFNB3 Anticorps) levels found in non-squamous than in squamous tumors.
These results suggest that EphA2/Efna1/Egfr genes, linked to a possible control by miR-200a and miR-26b, could be proposed as novel CRC prognostic biomarkers. Moreover, EphA2 could be linked to a mechanism of resistance to cetuximab alternative to KRAS mutations.
the dimer structures of human EphA2 receptor depend on the lipid environment, which we show is linked to the location of the structural motifs in the dimer interface, thereby establishing that both sequence and membrane composition modulate the complete energy landscape of membrane-bound proteins.
data suggest that novel germ-line (blood) and somatic (lens) coding SNVs in EPHA2 that are predicted to be functionally deleterious occur in adults over 50 years of age
The YSA peptide stabilizes the EphA2 dimer.
A 3D structural model of a mutant with a novel 39-AA polypeptide at the C-terminus had partial disorder in the acquired C-terminal tail and a few residues making an alpha-helix and 2 short beta-strands. 2 peptides comprising the whole C-terminus and its predicted helical region, respectively, did not interact with EphA2-Sam (Montrer TTN Anticorps) or Ship2 (Montrer INPPL1 Anticorps)-Sam (Montrer TTN Anticorps). The C-terminus should not wrap the EphA2-Sam (Montrer TTN Anticorps) End-Helix interface or affect Sam (Montrer TTN Anticorps) dom (Montrer SOX10 Anticorps)...

Cow (Bovine) EPH Receptor A2 (EPHA2) interaction partners

The present study successfully assessed the expression pattern of miR26b in the pituitary tissue of Yanbian cattle, and also confirmed that EphA2 was a target gene of miR26b in Yanbian cattle in vitro.

Mouse (Murine) EPH Receptor A2 (EPHA2) interaction partners

These results suggest that EphA2/Efna1/Egfr genes, linked to a possible control by miR-200a and miR-26b, could be proposed as novel CRC prognostic biomarkers. Moreover, EphA2 could be linked to a mechanism of resistance to cetuximab alternative to KRAS mutations.
Collectively, these data suggest that ATRA attenuates bleomycin-induced pulmonary fibrosis by regulating EphA2-EphrinA1 and PI3K-Akt (Montrer AKT1 Anticorps) signaling.
Lipopolysaccharide exposure significantly up-regulated EphA2 and EphrinA1 expression.
modulation of EphA2 signaling might contribute to effective transplantation of tissue-specific resident macrophages and/or monocytes
Our data suggest that EphA2 is closely related to the formation of osteoblasts and resorption of osteoclast and is likely to play an role in bone resorption induced in chronic periodontitis
We examined the roles of ephrin-A2 (Montrer EFNA2 Anticorps) and ephrin-A5 (Montrer EFNA5 Anticorps) signaling in contralateral targeting and topographic ordering in the ventral cochlear nucleus
EphA2 acts as a KRas cooperative tumor suppressor
Data shows that modulation of angiostatic factor Slit2 (Montrer SLIT2 Anticorps) by EphA2 receptor regulates endothelial responses to VEGF (Montrer VEGFA Anticorps)-mediated angiogenesis and tumor neovascularization.
Sporozoites productively infected hepatocytes with high EphA2 expression, and the deletion of EphA2 protected mice from liver infection.
EphA2-mutant mice are more prone to hyperglycemia-induced increased injury and decreased survival.

EPH Receptor A2 (EPHA2) profil antigène

Antigen Summary

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.

Alternative names and synonyms associated with EPH Receptor A2 (EPHA2)

EPH receptor A2 (EPHA2) anticorps
Eph receptor A2 (Epha2) anticorps
EPH receptor A2 (epha2) anticorps
epoxide hydrolase (ephA2) anticorps
eph receptor A2 a (epha2a) anticorps
EPH receptor A2 L homeolog (epha2.L) anticorps
EPH receptor A2 (Epha2) anticorps

ARCC2 anticorps
AW545284 anticorps
CTPA anticorps
CTPP1 anticorps
CTRCT6 anticorps
Eck anticorps
epha2 anticorps
epha2-A anticorps
G42 anticorps
id:ibd5152 anticorps
MGC89505 anticorps
Myk2 anticorps
rtk6 anticorps
Sek-2 anticorps
Sek2 anticorps
XE10 anticorps

Protein level used designations for anti-EPH Receptor A2 (EPHA2) Anticorps

ephrin type-A receptor 2 , epithelial cell receptor protein tyrosine kinase , soluble EPHA2 variant 1 , tyrosine-protein kinase receptor ECK , ephrin receptor EphA2 , EphA2 , epoxide hydrolase , EPH receptor A2 , epithelial cell kinase , tyrosine-protein kinase receptor MPK-5 , tyrosine-protein kinase receptor SEK-2 , protein tyrosine kinase EphA2 , eph-like receptor tyrosine kinase 6 , EPH receptor A2 L homeolog , ephrin receptor EphA2 (tyrosine kinase family)

GENE ID	SPECIES
1969	Homo sapiens
366492	Rattus norvegicus
448450	Xenopus (Silurana) tropicalis
456472	Pan troglodytes
487421	Canis lupus familiaris
512798	Bos taurus
692343	Macaca mulatta
1214785	Streptomyces avermitilis MA-4680
100053644	Equus caballus
100591506	Nomascus leucogenys
13836	Mus musculus
771550	Gallus gallus
30689	Danio rerio
394370	Xenopus laevis
100343518	Oryctolagus cuniculus
100712747	Cavia porcellus

Fournisseurs de qualité sélectionnés pour anti-EPH Receptor A2 (EPHA2) Anticorps

Avez-vous cherché autre chose?

Tel:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@anticorps-enligne.fr